Topcon launches internet OCT image viewer

Article

The EyeRoute Image Management System, which provides a remote view of a Spectral Domain OCT system, has been introduced by Topcon Medical Systems.

The EyeRoute Image Management System, which provides a remote view of a Spectral Domain OCT system, has been introduced by Topcon Medical Systems.

New features of the EyeRoute include dynamic real-time viewing of the B-scan, and pinpoint display of the OCT and its corresponding fundus images; B-scans, digital retinal images and visual fields can also be viewed and manipulated remotely to be compared directly with the 3D OCT images.

The web interface internet link does not require OCT review station software and is compatible with the Topcon 3D OCT-1000 and Heidelberg Spectralis. Topcon is currently developing interfaces that are compatible with Cirrus, Optovue and Zeiss systems.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.